Advanced company searchLink opens in new window

MYRICX PHARMA LIMITED

Company number 12082645

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
25 Oct 2024 SH01 Statement of capital following an allotment of shares on 24 October 2024
  • GBP 336.27177
02 Oct 2024 AP01 Appointment of Dr Paolo Paoletti as a director on 20 September 2024
03 Sep 2024 RP04CS01 Second filing of Confirmation Statement dated 2 July 2024
  • ANNOTATION Clarification a second filed CS01 (Capital and Shareholders) was filed on 20/08/24
30 Aug 2024 SH01 Statement of capital following an allotment of shares on 19 August 2024
  • GBP 335.81925
15 Jul 2024 SH01 Statement of capital following an allotment of shares on 28 June 2024
  • GBP 335.81925
12 Jul 2024 SH01 Statement of capital following an allotment of shares on 28 June 2024
  • GBP 330.68138
09 Jul 2024 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES10 ‐ Resolution of allotment of securities
09 Jul 2024 MA Memorandum and Articles of Association
08 Jul 2024 CS01 Confirmation statement made on 2 July 2024 with updates
08 Jul 2024 AP01 Appointment of Michael Karl Bauer as a director on 28 June 2024
05 Jul 2024 AP01 Appointment of Dr Lucille Conroy as a director on 28 June 2024
05 Jul 2024 TM01 Termination of appointment of Edward William Tate as a director on 28 June 2024
20 Jun 2024 TM01 Termination of appointment of Rachael Brake as a director on 19 June 2024
20 May 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
14 Mar 2024 SH01 Statement of capital following an allotment of shares on 14 March 2024
  • GBP 170.68141
04 Mar 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
13 Feb 2024 SH01 Statement of capital following an allotment of shares on 8 February 2024
  • GBP 168.21577
07 Feb 2024 AA Total exemption full accounts made up to 31 July 2023
17 Nov 2023 TM01 Termination of appointment of Roberto Celeste Ercole Solari as a director on 10 November 2023
17 Nov 2023 AP01 Appointment of Christopher John Martin as a director on 10 November 2023
08 Sep 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
25 Aug 2023 SH01 Statement of capital following an allotment of shares on 24 August 2023
  • GBP 163.76563
05 Jul 2023 CS01 Confirmation statement made on 2 July 2023 with no updates
26 Apr 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
19 Apr 2023 AP01 Appointment of Dr Jonathan Leslie Tobin as a director on 19 April 2023